S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Argraves, Kelley M ^a   Sethi, Amar A ^b   Gazzolo, Patrick J ^a   Wilkerson, Brent A ^a   Remaley, Alan T ^b   Tybjaerg Hansen, Anne ^c   Nordestgaard, Børge G ^c   Yeatts, Sharon D ^d   Nicholas, Katherine S ^d   Barth, Jeremy L ^a   Argraves, W Scott ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c Mental Health Services CPH   (Denmark)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C24:1 CERAMIDE; CERAMIDE; DIHYDROSPHINGOSINE 1 PHOSPHATE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; DIHYDROSPHINGOSINE 1-PHOSPHATE; DRUG DERIVATIVE; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; SERUM; BLOOD; CELL MOTION; DENMARK; DRUG EFFECT; ENDOTHELIUM CELL; FRACTIONATION; HEART MUSCLE ISCHEMIA; IMPEDANCE; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; VASCULAR ENDOTHELIUM;

CELL MOVEMENT; CERAMIDES; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, LIQUID; DENMARK; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LIPOPROTEINS, HDL; LYSOPHOSPHOLIPIDS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ROC CURVE; SPHINGOLIPIDS; SPHINGOSINE;

EID: 79955677017     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-70     Document Type: Article

References (38)

1. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. Y Yatomi Y Igarashi L Yang N Hisano R Qi N Asazuma K Satoh Y Ozaki S Kume, Journal of biochemistry 1997 121 5 969 973 (Pubitemid 27236918)
2. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. N Murata K Sato J Kon H Tomura M Yanagita A Kuwabara M Ui F Okajima, Biochem J 2000 352 Pt 3 809 815 (Pubitemid 32015038)
3. HDL serves as an S1P signaling platform mediating a multitude of cardiovascular effects. KM Argraves WS Argraves, J Lipid Res 2007 48 11 2325 2333 (Pubitemid 350058744)
4. Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection. K Sattler B Levkau, Cardiovasc Res 2009 82 2 201 211
5. High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function. KM Argraves PJ Gazzolo EM Groh BA Wilkerson BS Matsuura WO Twal SM Hammad WS Argraves, J Biol Chem 2008 283 36 25074 25081
6. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media. BG Nordestgaard R Wootton B Lewis, Arterioscler Thromb Vasc Biol 1995 15 4 534 542
7. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. T Gordon WP Castelli MC Hjortland WB Kannel TR Dawber, The American journal of medicine 1977 62 5 707 714 (Pubitemid 8110784)
8. Lipoproteins, cardiovascular disease, and death. The Framingham study. T Gordon WB Kannel WP Castelli TR Dawber, Archives of internal medicine 1981 141 9 1128 1131 (Pubitemid 11017493)
9. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. DJ Gordon JL Probstfield RJ Garrison JD Neaton WP Castelli JD Knoke DR Jacobs Jr S Bangdiwala HA Tyroler, Circulation 1989 79 1 8 15 (Pubitemid 19043669)
10. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. BJ Ansell M Navab S Hama N Kamranpour G Fonarow G Hough S Rahmani R Mottahedeh R Dave ST Reddy,, et al. Circulation 2003 108 22 2751 2756 (Pubitemid 37498976)
11. EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes. P Robert P Tsui MP Laville GP Livi HM Sarau A Bril I Berrebi-Bertrand, J Mol Cell Cardiol 2001 33 9 1589 1606 (Pubitemid 32844218)
12. Extracellular mechanism through the Edg family of receptors might be responsible for sphingosine-1-phosphate-induced regulation of DNA synthesis and migration of rat aortic smooth-muscle cells. K Tamama J Kon K Sato H Tomura A Kuwabara T Kimura T Kanda H Ohta M Ui I Kobayashi,, et al. Biochem J 2001 353 Pt 1 139 146 (Pubitemid 32094608)
13. Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. T Kimura T Watanabe K Sato J Kon H Tomura K Tamama A Kuwabara T Kanda I Kobayashi H Ohta,, et al. Biochem J 2000 348 Pt 1 71 76 (Pubitemid 30312132)
14. Endothelial cell barrier regulation by sphingosine 1-phosphate. BJ McVerry JG Garcia, J Cell Biochem 2004 92 6 1075 1085 (Pubitemid 44264219)
15. The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. LH Kuller JE Eichner TJ Orchard GA Grandits L McCallum RP Tracy, American journal of epidemiology 1991 134 11 1266 1277
16. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. DH Deutschman JS Carstens RL Klepper WS Smith MT Page TR Young LA Gleason N Nakajima RA Sabbadini, Am Heart J 2003 146 1 62 68 (Pubitemid 36851301)
17. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. E Camerer JB Regard I Cornelissen Y Srinivasan DN Duong D Palmer TH Pham JS Wong R Pappu SR Coughlin, J Clin Invest 2009 119 7 1871 1879
18. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. R Pappu SR Schwab I Cornelissen JP Pereira JB Regard Y Xu E Camerer YW Zheng Y Huang JG Cyster,, et al. Science 2007 316 5822 295 298 (Pubitemid 46633109)
19. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. KJ Sattler S Elbasan P Keul M Elter-Schulz C Bode MH Graler M Brocker-Preuss T Budde R Erbel G Heusch,, et al. Basic Res Cardiol 2010 105 6 821 832
20. Association of ceramides in human plasma with risk factors of atherosclerosis. I Ichi K Nakahara Y Miyashita A Hidaka S Kutsukake K Inoue T Maruyama Y Miwa M Harada-Shiba M Tsushima,, et al. Lipids 2006 41 9 859 863 (Pubitemid 44788907)
21. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. BG Nordestgaard M Benn P Schnohr A Tybjaerg-Hansen, JAMA 2007 298 3 299 308 (Pubitemid 47080484)
22. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. I Graham D Atar K Borch-Johnsen G Boysen G Burell R Cifkova J Dallongeville G De Backer S Ebrahim B Gjelsvik,, et al. Atherosclerosis 2007 194 1 1 45 (Pubitemid 47470068)
23. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 285 19 2486 2497
24. Adenosine triphosphate binding cassette (ABC) transporters are expressed and regulated during terminal keratinocyte differentiation: a potential role for ABCA7 in epidermal lipid reorganization. D Kielar WE Kaminski G Liebisch A Piehler JJ Wenzel C Mohle S Heimerl T Langmann SO Friedrich A Bottcher,, et al. J Invest Dermatol 2003 121 3 465 474 (Pubitemid 37072254)
25. Potential role of ABCA7 in cellular lipid efflux to apoA-I. P Linsel-Nitschke AW Jehle J Shan G Cao D Bacic D Lan N Wang AR Tall, J Lipid Res 2005 46 1 86 92 (Pubitemid 40066674)
26. Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2-Ets1 pathway in human fibroblasts. S Bu M Yamanaka H Pei A Bielawska J Bielawski YA Hannun L Obeid M Trojanowska, Faseb J 2006 20 1 184 186 (Pubitemid 43100508)
27. ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. V Lemaitre TK O'Byrne AC Borczuk Y Okada AR Tall J D'Armiento, J Clin Invest 2001 107 10 1227 1234 (Pubitemid 32494539)
28. Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease. S Ye CR Gale CN Martyn, European heart journal 2003 24 18 1668 1671 (Pubitemid 37174907)
29. Prevalence-value-accuracy plots: a new method for comparing diagnostic tests based on misclassification costs. AT Remaley ML Sampson JM DeLeo NA Remaley BD Farsi MH Zweig, Clin Chem 1999 45 7 934 941 (Pubitemid 29340528)
30. Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study. P Schnohr JS Jensen H Scharling BG Nordestgaard, European heart journal 2002 23 8 620 626 (Pubitemid 35204246)
31. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. R Frikke-Schmidt BG Nordestgaard MC Stene AA Sethi AT Remaley P Schnohr P Grande A Tybjaerg-Hansen, JAMA 2008 299 21 2524 2532 (Pubitemid 351787208)
32. Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease. TH Johannsen PR Kamstrup RV Andersen GB Jensen H Sillesen A Tybjaerg-Hansen BG Nordestgaard, J Clin Endocrinol Metab 2009 94 4 1264 1273
33. Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. K Juul A Tybjaerg-Hansen R Steffensen S Kofoed G Jensen BG Nordestgaard, Blood 2002 100 1 3 10 (Pubitemid 35177420)
34. High pre-beta1 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol. AA Sethi M Sampson R Warnick N Muniz B Vaisman BG Nordestgaard A Tybjaerg-Hansen AT Remaley, Clin Chem 2010 56 7 1128 1137
35. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. GR Warnick J Benderson JJ Albers, Clin Chem 1982 28 6 1379 1388 (Pubitemid 12125081)
36. Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. J Bielawski ZM Szulc YA Hannun A Bielawska, Methods 2006 39 2 82 91 (Pubitemid 44107706)
37. Lipoprotein Isolation and Analysis from Serum by Preparative Ultracentrifugation. KM Wasan SM Cassidy AL Kennedy KD Peteherych, Atherosclerosis: experimental methods and protocols Totowa, NJ: Humana Press, Drew AF, 2000 27 35
38. A morphological biosensor for mammalian cells. I Giaever CR Keese, Nature 1993 366 6455 591 592 (Pubitemid 24036004)